Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.

• Published in: PLOS Neglected Tropical Diseases
• Main Authors: Reza A Niles, Charles R Thickstun, Horace Cox, Daniel Dilliott, Clara R Burgert-Brucker, Emma M Harding-Esch, Nikita Clementson, Annastacia Sampson, Jean Seme Alexandre, Ana C Morice Trejos, Ronaldo G Carvalho Scholte, Alison Krentel
• Format: Article in Journal/Newspaper
• Language: English
• Published: Public Library of Science (PLoS) 2021
• Subjects: Arctic medicine. Tropical medicine; RC955-962; Public aspects of medicine; RA1-1270; Arctic; Ida
• Online Access: https://doi.org/10.1371/journal.pntd.0009596; https://doaj.org/article/0b1b563103284b228fb03e3eaf669527

Background Guyana is one of four countries in the Latin American Region where lymphatic filariasis (LF) remains endemic. In preparation for the introduction of a new triple drug therapy regimen (ivermectin, diethylcarbamazine, and albendazole (IDA)) in 2019, an acceptability study was embedded withi...